These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28077081)

  • 1. Antigen presenting capacity of murine splenic myeloid cells.
    Hey YY; Quah B; O'Neill HC
    BMC Immunol; 2017 Jan; 18(1):4. PubMed ID: 28077081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCSF drives regulatory DC development in stromal co-cultures supporting hematopoiesis.
    Petvises S; Periasamy P; O'Neill HC
    BMC Immunol; 2018 Jun; 19(1):21. PubMed ID: 29940852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel antigen cross-presenting cell type in spleen.
    Tan JK; Quah BJ; Griffiths KL; Periasamy P; Hey YY; O'Neill HC
    J Cell Mol Med; 2011 May; 15(5):1189-99. PubMed ID: 20477902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel myeloid cell in murine spleen defined through gene profiling.
    Hey YY; O'Neill TJ; O'Neill HC
    J Cell Mol Med; 2019 Aug; 23(8):5128-5143. PubMed ID: 31210415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity.
    Quah B; Ni K; O'Neill HC
    Int Immunol; 2004 Apr; 16(4):567-77. PubMed ID: 15039387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function.
    Hey YY; O'Neill HC
    J Cell Mol Med; 2012 Nov; 16(11):2611-9. PubMed ID: 22862733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic stem cells in spleen have distinct differentiative potential for antigen presenting cells.
    Tan JK; O'Neill HC
    J Cell Mol Med; 2010 Aug; 14(8):2144-50. PubMed ID: 19799644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells.
    León B; Martínez del Hoyo G; Parrillas V; Vargas HH; Sánchez-Mateos P; Longo N; López-Bravo M; Ardavín C
    Blood; 2004 Apr; 103(7):2668-76. PubMed ID: 14630812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Intrasplenic Migration of Dendritic Cell Subsets Tailors Adaptive Immunity.
    Calabro S; Liu D; Gallman A; Nascimento MS; Yu Z; Zhang TT; Chen P; Zhang B; Xu L; Gowthaman U; Krishnaswamy JK; Haberman AM; Williams A; Eisenbarth SC
    Cell Rep; 2016 Aug; 16(9):2472-85. PubMed ID: 27545885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen.
    Ryu SH; Shin HS; Eum HH; Park JS; Choi W; Na HY; In H; Kim TG; Park S; Hwang S; Sohn M; Kim ED; Seo KY; Lee HO; Lee MG; Chu MK; Park CG
    Front Immunol; 2021; 12():767037. PubMed ID: 35069539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity.
    Voisine C; Hubert FX; Trinité B; Heslan M; Josien R
    J Immunol; 2002 Sep; 169(5):2284-91. PubMed ID: 12193693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of endocytosis, degradative activity, and antigen processing capacity during GM-CSF driven differentiation of murine bone marrow.
    Olatunde AC; Abell LP; Landuyt AE; Hiltbold Schwartz E
    PLoS One; 2018; 13(5):e0196591. PubMed ID: 29746488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
    Pooley JL; Heath WR; Shortman K
    J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells.
    Ferlazzo G; Wesa A; Wei WZ; Galy A
    J Immunol; 1999 Oct; 163(7):3597-604. PubMed ID: 10490952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.
    den Haan JM; Lehar SM; Bevan MJ
    J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.